Tumor genomic subtypes orthogonal to mutation burden predict the efficacy of immune checkpoint therapy

Shiro Takamatsu, Junzo Hamanishi, J.B. Brown, Ken Yamaguchi, Koji Yamanoi, Kosuke Murakami, Osamu Gotoh, Seiichi Mori, Masaki Mandai, Noriomi Matsumura
doi: https://doi.org/10.1101/2021.10.03.21264330

Data Availability

Controlled access data used in this study were obtained from dbGaP, EGA, and NBDC with access permissions according to the respective required procedures. The processed data and analysis codes to reproduce the results of this work are available on the GitHub page (https://github.com/shirotak/pancancer_MutSig_ICI). Other codes for preprocessing or restricted-access data are available from the corresponding author upon reasonable request.

https://github.com/shirotak/pancancer_MutSig_ICI

Back to top
Posted October 04, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Tumor genomic subtypes orthogonal to mutation burden predict the efficacy of immune checkpoint therapy
Shiro Takamatsu, Junzo Hamanishi, J.B. Brown, Ken Yamaguchi, Koji Yamanoi, Kosuke Murakami, Osamu Gotoh, Seiichi Mori, Masaki Mandai, Noriomi Matsumura
medRxiv 2021.10.03.21264330; doi: https://doi.org/10.1101/2021.10.03.21264330
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area